Tema Cardiovascular and Metabolic ETF
Limited financial coverage for HRTS.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
The Tema Heart & Health ETF (HRTS) is designed to strategically invest in companies poised to benefit from cutting-edge developments within the biotechnology and broader healthcare industries. Its investment mandate specifically targets firms focused on advancing treatments and therapies for cardiovascular health, metabolic disorders, and weight management.
- IPO
- 2023
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on HRTS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $56.71M
- Div Yield
- 1.24%
- 52W High
- $38.87
- 52W Low
- $29.02
- 50D MA
- $36.35
- 200D MA
- $35.04
- Beta
- 0.65
- RSI (14)
- 62
- Avg Volume
- 5.75K
No earnings-call transcripts are available for HRTS yet.
- Free Float
- 0.0%
- Shares Outstanding
- 1.48M
- Float Shares
- 0
of shares held by institutions
14 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Oliver Lagore Vanvalin Investment Group | 30.84K | ▲ 30.84K |
Our HRTS coverage
Recent articles, reports, and earnings notes.
No research on HRTS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HRTS report →Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage
zacks.com · Jul 1
Tema ETFs Exceeds $5bn in AUM After Three Years
businesswire.com · Jun 15
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
zacks.com · Jun 10
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain
zacks.com · May 19
Tema ETFs Surpasses $2 Billion in AUM in Under Three Years
businesswire.com · Apr 16
Tema Heart & Health ETF (NASDAQ:HRTS) Shares Down 1.5% – Time to Sell?
defenseworld.net · Mar 4
Tema Appoints ETF Industry Leader Steve Munroe as President
businesswire.com · Feb 18
New Year, New Strategy: Navigating Weight Loss ETFs
etftrends.com · Jan 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.